CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionToroso Investments, LLC
Latest Disclosed Ownership160,106 shares
Latest Disclosed Value $ 47,287,307
Toroso Investments, LLC reports 13.18% decrease in ownership of MX4A / CME Group Inc.

On May 15, 2026 - Toroso Investments, LLC filed a 13F-HR form disclosing ownership of 160,106 shares of CME Group Inc. (BG:MX4A) valued at $47,287,307 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 184,406 shares of CME Group Inc.. This represents a change in shares of -13.18% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CME GROUP COM 12572Q105 160,106 -24,300 -13.18 47,287 -6.10 0.0997
2026-02-13 2025-12-31 13F CME GROUP COM 12572Q105 184,406 -35,066 -15.98 50,358 -15.08 0.1195
2025-11-14 2025-09-30 13F CME GROUP COM 12572Q105 219,472 117,161 114.51 59,299 110.30 0.1186
2025-08-14 2025-06-30 13F CME GROUP COM 12572Q105 102,311 30,665 42.80 28,199 48.36 0.1695
2025-05-14 2025-03-31 13F CME GROUP COM 12572Q105 71,646 -8,031 -10.08 19,007 2.72 0.1546
2025-02-14 2024-12-31 13F CME GROUP COM 12572Q105 79,677 5,980 8.11 18,503 13.79 0.1455
2024-11-25 2024-09-30 13F/A-1 CME GROUP COM 12572Q105 73,697 -5,225 -6.62 16,261 4.80 0.1719
2024-11-14 2024-09-30 13F CME GROUP COM 12572Q105 73,697 -5,225 16,261 0.1113
2024-08-14 2024-06-30 13F CME GROUP COM 12572Q105 78,922 -6,487 -7.60 15,516 -15.61 0.2085
2024-05-16 2024-03-31 13F CME GROUP COM 12572Q105 85,409 -45,320 -34.67 18,388 -33.21 0.3035
2024-02-15 2023-12-31 13F CME GROUP COM 12572Q105 130,729 65,892 101.63 27,532 112.09 0.6406
2023-11-15 2023-09-30 13F CME GROUP COM 12572Q105 64,837 -13,930 -17.69 12,982 92,621.43 0.3949
2023-08-14 2023-06-30 13F CME GROUP COM 12572Q105 78,767 -31,790 -28.75 15 -33.33 0.4290
2023-05-23 2023-03-31 13F/A-1 CME GROUP COM 12572Q105 110,557 3,040 2.83 21 -99.88 0.6970
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 110,557 3,040 21 0.7514
2023-02-15 2022-12-31 13F CME GROUP COM 12572Q105 107,517 -10,834 -9.15 18,080 -13.75 0.6948
2022-11-23 2022-09-30 13F CME GROUP COM 12572Q105 118,351 -18,410 -13.46 20,963 -25.12 0.8711
2022-08-15 2022-06-30 13F CME GROUP COM 12572Q105 136,761 -49,797 -26.69 27,995 -36.91 1.0256
2022-05-20 2022-03-31 13F CME GROUP COM 12572Q105 186,558 -26,397 -12.40 44,375 -8.79 1.3220
2022-02-16 2021-12-31 13F CME GROUP COM 12572Q105 212,955 47,766 28.92 48,651 52.30 1.4896
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 165,189 55,485 50.58 31,945 36.91 1.1951
2021-08-13 2021-06-30 13F CME GROUP COM 12572Q105 109,704 46,626 73.92 23,332 81.11 0.9115
2021-05-17 2021-03-31 13F CME GROUP COM 12572Q105 63,078 42,513 206.73 12,883 244.10 0.6026
2021-02-16 2020-12-31 13F CME GROUP COM 12572Q105 20,565 10,180 98.03 3,744 115.42 0.2588
2020-11-16 2020-09-30 13F CME GROUP COM 12572Q105 10,385 1,031 11.02 1,738 14.34 0.2321
2020-08-17 2020-06-30 13F CME GROUP COM 12572Q105 9,354 -104 -1.10 1,520 -7.03 0.2064
2020-05-08 2020-03-31 13F CME GROUP COM 12572Q105 9,458 -1,059 -10.07 1,635 -22.55 0.4849
2020-02-14 2019-12-31 13F CME GROUP COM 12572Q105 10,517 29 0.28 2,111 -4.78 0.8895
2019-11-14 2019-09-30 13F CME GROUP COM 12572Q105 10,488 -368 -3.39 2,217 5.22 0.9998
2019-08-15 2019-06-30 13F CME GROUP COM 12572Q105 10,856 4,160 62.13 2,107 91.20 1.1613
2019-05-15 2019-03-31 13F CME GROUP COM CL A 12572Q105 6,696 -3,412 -33.76 1,102 -42.06 0.7416
2019-02-14 2018-12-31 13F CME GROUP COM CL A 12572Q105 10,108 10,108 1,902 1.4657
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.